RU-505

RU-505 Suppliers list
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: Pharmacodia (Beijing) Co.,Ltd  
Tel: +86-400-851-9921
Email: sales@pharmacodia.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com
Company Name: Lynnchem  
Tel: 86-(0)29-85992781 17792393971
Email: info@lynnchem.com

RU-505 manufacturers

  • RU-505
  • RU-505 pictures
  • $198.00
  • 2026-05-11
  • CAS:1314206-29-5
  • Purity:
  • Supply Ability: 10g
RU-505 Basic information
Product Name:RU-505
Synonyms:RU-505;Pyrazolo[1,5-a]pyrimidine-5-carboxamide, N-[2-(dimethylamino)ethyl]-2-(1,1-dimethylethyl)-7-(4-fluorophenyl)-N-(phenylmethyl)-
CAS:1314206-29-5
MF:C28H32FN5O
MW:473.58
EINECS:
Product Categories:
Mol File:1314206-29-5.mol
RU-505 Structure
RU-505 Chemical Properties
storage temp. Store at -20°C
solubility DMF: 30 mg/ml; DMSO: 30 mg/ml; DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml; Ethanol: 0.5 mg/ml
form A crystalline solid
Safety Information
MSDS Information
RU-505 Usage And Synthesis
DescriptionRU-505 is an inhibitor of the interaction between amyloid-β (Aβ) and fibrinogen, with a higher efficacy for inhibiting monomeric forms of Aβ bound to fibrinogen over oligomeric forms. In vitro, RU-505 (20 μM) normalizes fibrin clot formation that is disrupted when fibrinogen is bound to Aβ42. RU-505 (35 mg/kg) decreases the incidence of vessel occlusion in the Tg6799 transgenic mouse model of Alzheimer’s disease. Chronic treatment with RU-505 (35 mg/kg, s.c., every other day for 3 months) decreases Aβ deposition in blood vessels and cortical fibrinogen infiltration and microgliosis in the brain of Tg6799 mice. In addition, it improves spatial memory in chronically treated Tg6799 mice compared with vehicle control mice.
UsesRU-505 is an effective β-amyloid (Aβ)-fibrinogen interaction inhibitor with IC50s of 5.00 and 2.72 μM in fluorescence polarization (FP) and AlphaLISA assays, respectively. RU-505 is highly permeable to the BBB. RU-505 reduces cerebral amyloid angiopathy (CAA). RU-505 can be used for the research of Alzheimer’s disease (AD)[1].
References[1] Hyung Jin Ahn, et al. A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice. J Exp Med. 2014 Jun 2;211(6):1049-62. DOI:10.1084/jem.20131751
RU-505 Preparation Products And Raw materials
Tag:RU-505(1314206-29-5) Related Product Information
Rhynchophylline Panaxadiol GINSENOSIDEF1 Ru 24969 SUN11602 Amyloid β-Protein (1-42) (mouse, rat)